DCT

1:22-cv-01040

Novo Nordisk Inc v. Mylan Pharma Inc

General

Filed

08/08/22

Cause of ActionPatent Infringement

SectorMech Eng, Manuf

Status

Closed (09/11/24)

Patent Owner

Operating Company (L)

PACER1:22-cv-01040

Nature of Suit835 ANDA

CourtD. Delaware

Judge	Period	PO Win Rate
Colm F. Connolly	--	41%

Plaintiff

Party

Name	Ratings
Novo Nordisk Inc	L2E
Novo Nordisk As	L2E

Attorney

Name	Ratings
Morris Nichols Arsht & Tunnell LLPLocal	L5A
Jack B. Blumenfeld	L5A
Brian P. Egan	L5A
Travis J. Murray	L1E
Fenwick & West LLP	L4A
Jeffrey J. Oelke	L5A
Robert Counihan	L5A
Ryan P. Johnson	L5A
Laura Moran	L4B
Silvia Medina	L4D
Olivia L. Wheeling	L3B
Michelle E. Irwin	L3C
Vanessa Park-Thompson	L3D
Erica R. Sutter	L3E
Retley G. Locke	L2C
Ryan Haddad	L1C
Schrader BYRD & Companion PLLCLocal	L1C
James F. Companion	L1C
Sandra K. Law	L1D
Attorney at LawLocal	---- --
Michael Yoon	---- --

Defendant

Party

Name	Ratings
Mylan Pharmaceuticals Inc	L5A

Attorney

Name	Ratings
Perkins Coie LLP	L5A
Shannon Bloodworth	L5A
Brandon M. White	L5B
Bryan D. Beel	L5C
David L. Anstaett	L5E
Maria A. Stubbings	L4C
Emily Greb	L4D
Courtney Prochnow	L4E
Michael R. Laing	L3C
Christopher D. Jones	L3D
Jonathan Tietz	L2B
Aaron E. Schindler	L2B
Steptoe & Johnson LLP	L4E
Gordon H. Copland	L5D
William J. O'Brien	L5E
Stamoulis & WeinblattLocal	L3E
Richard C. Weinblatt	L5E
Stamatios Stamoulis	L5E